Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
39.46
-0.05 (-0.13%)
At close: Apr 28, 2026, 4:00 PM EDT
39.45
-0.02 (-0.04%)
After-hours: Apr 28, 2026, 4:10 PM EDT

Centessa Pharmaceuticals Statistics

Total Valuation

CNTA has a market cap or net worth of $6.10 billion. The enterprise value is $5.93 billion.

Market Cap 6.10B
Enterprise Value 5.93B

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026, before market open.

Earnings Date May 13, 2026
Ex-Dividend Date n/a

Share Statistics

CNTA has 154.66 million shares outstanding. The number of shares has increased by 18.56% in one year.

Current Share Class n/a
Shares Outstanding 154.66M
Shares Change (YoY) +18.56%
Shares Change (QoQ) +5.83%
Owned by Insiders (%) 0.64%
Owned by Institutions (%) 58.91%
Float 97.92M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 406.86
Forward PS n/a
PB Ratio 11.18
P/TBV Ratio 11.58
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 395.12
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.57, with a Debt / Equity ratio of 0.22.

Current Ratio 8.57
Quick Ratio 8.27
Debt / Equity 0.22
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -18.12

Financial Efficiency

Return on equity (ROE) is -42.55% and return on invested capital (ROIC) is -22.29%.

Return on Equity (ROE) -42.55%
Return on Assets (ROA) -20.53%
Return on Invested Capital (ROIC) -22.29%
Return on Capital Employed (ROCE) -32.22%
Weighted Average Cost of Capital (WACC) 11.11%
Revenue Per Employee $127,119
Profits Per Employee -$1.67M
Employee Count 118
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

In the past 12 months, CNTA has paid $1.82 million in taxes.

Income Tax 1.82M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +186.15% in the last 52 weeks. The beta is 1.26, so CNTA's price volatility has been higher than the market average.

Beta (5Y) 1.26
52-Week Price Change +186.15%
50-Day Moving Average 32.00
200-Day Moving Average 24.80
Relative Strength Index (RSI) 73.36
Average Volume (20 Days) 5,367,312

Short Selling Information

The latest short interest is 3.47 million, so 2.58% of the outstanding shares have been sold short.

Short Interest 3.47M
Short Previous Month 6.61M
Short % of Shares Out 2.58%
Short % of Float n/a
Short Ratio (days to cover) 0.73

Income Statement

In the last 12 months, CNTA had revenue of $15.00 million and -$197.53 million in losses. Loss per share was -$1.46.

Revenue 15.00M
Gross Profit 15.00M
Operating Income -207.69M
Pretax Income -195.71M
Net Income -197.53M
EBITDA -207.37M
EBIT -207.69M
Loss Per Share -$1.46
Full Income Statement

Balance Sheet

The company has $294.58 million in cash and $118.38 million in debt, giving a net cash position of $176.20 million or $1.14 per share.

Cash & Cash Equivalents 294.58M
Total Debt 118.38M
Net Cash 176.20M
Net Cash Per Share $1.14
Equity (Book Value) 526.86M
Book Value Per Share 3.53
Working Capital 324.94M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$193.82 million and capital expenditures -$371,000, giving a free cash flow of -$194.19 million.

Operating Cash Flow -193.82M
Capital Expenditures -371,000
Depreciation & Amortization 321,000
Net Borrowing n/a
Free Cash Flow -194.19M
FCF Per Share -$1.26
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -1,384.61%
Pretax Margin -1,304.75%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CNTA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -18.56%
Shareholder Yield -18.56%
Earnings Yield -3.24%
FCF Yield -3.18%

Analyst Forecast

The average price target for CNTA is $43.17, which is 9.40% higher than the current price. The consensus rating is "Buy".

Price Target $43.17
Price Target Difference 9.40%
Analyst Consensus Buy
Analyst Count 9
Revenue Growth Forecast (5Y) 87.10%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CNTA has an Altman Z-Score of 6.37 and a Piotroski F-Score of 1.

Altman Z-Score 6.37
Piotroski F-Score 1